Stock analysts at William Blair assumed coverage on shares of LifePoint Health, Inc. (NASDAQ:LPNT) in a research note issued on Tuesday. The firm set an “outperform” rating on the stock.

Several other analysts have also weighed in on the company. Credit Suisse Group started coverage on LifePoint Health in a research note on Thursday, November 2nd. They issued a “neutral” rating and a $54.00 price objective on the stock. ValuEngine lowered LifePoint Health from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. Zacks Investment Research raised LifePoint Health from a “sell” rating to a “hold” rating in a research note on Monday, September 11th. Leerink Swann reiterated an “outperform” rating and issued a $58.00 target price (down from $74.00) on shares of LifePoint Health in a research report on Tuesday, October 31st. They noted that the move was a valuation call. Finally, SunTrust Banks, Inc. set a $60.00 target price on LifePoint Health and gave the company a “hold” rating in a research report on Thursday, October 12th. Two research analysts have rated the stock with a sell rating, twelve have issued a hold rating and five have issued a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $60.23.

Shares of LifePoint Health (LPNT) opened at $45.30 on Tuesday. The firm has a market capitalization of $1,730.00, a PE ratio of 11.02, a P/E/G ratio of 1.12 and a beta of 0.68. The company has a debt-to-equity ratio of 1.24, a current ratio of 1.85 and a quick ratio of 1.65. LifePoint Health has a 12 month low of $42.50 and a 12 month high of $70.95.

LifePoint Health (NASDAQ:LPNT) last released its quarterly earnings data on Friday, October 27th. The company reported $0.80 earnings per share for the quarter, missing the consensus estimate of $0.95 by ($0.15). The business had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.60 billion. LifePoint Health had a net margin of 2.45% and a return on equity of 7.01%. The business’s quarterly revenue was down .7% compared to the same quarter last year. During the same period last year, the business earned $0.94 earnings per share. equities analysts predict that LifePoint Health will post 3.65 EPS for the current fiscal year.

LifePoint Health announced that its Board of Directors has authorized a share buyback program on Friday, October 27th that allows the company to repurchase $200.00 million in shares. This repurchase authorization allows the company to repurchase shares of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s board believes its stock is undervalued.

TRADEMARK VIOLATION WARNING: This piece of content was posted by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark legislation. The correct version of this piece of content can be viewed at https://www.dailypolitical.com/2017/11/23/lifepoint-health-inc-lpnt-now-covered-by-william-blair.html.

In other LifePoint Health news, Director Marguerite Kondracke sold 3,416 shares of LifePoint Health stock in a transaction that occurred on Tuesday, November 21st. The stock was sold at an average price of $43.80, for a total value of $149,620.80. Following the completion of the sale, the director now directly owns 17,479 shares in the company, valued at $765,580.20. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 8.76% of the company’s stock.

Institutional investors have recently made changes to their positions in the business. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in LifePoint Health by 10.8% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,678 shares of the company’s stock valued at $113,000 after acquiring an additional 164 shares during the period. LS Investment Advisors LLC grew its stake in LifePoint Health by 43.7% in the second quarter. LS Investment Advisors LLC now owns 1,785 shares of the company’s stock valued at $120,000 after acquiring an additional 543 shares during the period. US Bancorp DE grew its stake in LifePoint Health by 0.8% in the second quarter. US Bancorp DE now owns 1,947 shares of the company’s stock valued at $130,000 after acquiring an additional 16 shares during the period. Shelton Capital Management acquired a new stake in LifePoint Health in the second quarter valued at approximately $205,000. Finally, Teacher Retirement System of Texas grew its stake in LifePoint Health by 0.3% in the second quarter. Teacher Retirement System of Texas now owns 3,211 shares of the company’s stock valued at $216,000 after acquiring an additional 9 shares during the period. 99.18% of the stock is owned by hedge funds and other institutional investors.

LifePoint Health Company Profile

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Analyst Recommendations for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.